Ovarian Hormones, Menstrual Cycle Phase, and Smoking: a Review with Recommendations for Future Studies

Current Addiction Reports

Volumn 3, Issue 1, 2016, Pages

  Wetherill, Reagan R ^a   Franklin, Teresa R ^a   Allen, Sharon S ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Menstrual phase; Nicotine; Ovarian hormones; Review; Women

Indexed keywords

EID: 84982246694     PISSN: None     EISSN: 21962952     Source Type: Journal    
DOI: 10.1007/s40429-016-0093-z     Document Type: Review

References (54)

1. United States Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2014.
2. Xu X, Bishop EE, Kennedy SM, Simpson SA, Pechacek TF. Annual healthcare spending attributable to cigarette smoking: an update. Am J Prev Med. 2015;48(3):326–33. doi:10.1016/j.amepre.2014.10.012.
3. Jamal A, Agaku IT, O’Connor E, King BA, Kenemer JB, Neff L. Current Cigarette Smoking Among Adults - United States, 2005-2013. Morb Mortal Wkly Rep (MMWR) 2014.
4. Perkins KA, Karelitz JL, Giedgowd GE, Conklin CA. Negative mood effects on craving to smoke in women versus men. Addict Behav. 2013;38(2):1527–31. doi:10.1016/j.addbeh.2012.06.002.
5. Perkins KA, Giedgowd GE, Karelitz JL, Conklin CA, Lerman C. Smoking in response to negative mood in men versus women as a function of distress tolerance. Nicotine Tob Res. 2012;14(12):1418–25. doi:10.1093/ntr/nts075.
6. Schnoll RA, Patterson F, Lerman C. Treating tobacco dependence in women. J Womens Health (Larchmt). 2007;16(8):1211–8. doi:10.1089/jwh.2006.0281.
7. Vogel RI, Hertsgaard LA, Dermody SS, Luo X, Moua L, Allen S, et al. Sex differences in response to reduced nicotine content cigarettes. Addict Behav. 2014;39(7):1197–204. doi:10.1016/j.addbeh.2014.03.021.
8. Perkins KA, Doyle T, Ciccocioppo M, Conklin C, Sayette M, Caggiula A. Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking. Psychopharmacology (Berl). 2006;184(3-4):600–7. doi:10.1007/s00213-005-0103-7.
9. Perkins KA. Sex differences in nicotine reinforcement and reward: influences on the persistence of tobacco smoking. Nebr Symp Motiv. 2009;55:143–69.
10. Van Voorhees EE, Mitchell JT, McClernon FJ, Beckham JC, Kollins SH. Sex, ADHD symptoms, and smoking outcomes: an integrative model. Med Hypotheses. 2012;78(5):585–93. doi:10.1016/j.mehy.2012.01.034.
11. Smith PH, Kasza KA, Hyland A, Fong GT, Borland R, Brady K, et al. Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey. Nicotine Tob Res. 2015;17(4):463–72. doi:10.1093/ntr/ntu212.
12. Scharf D, Shiffman S. Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR. Addiction. 2004;99(11):1462–9.
13. Schnoll RA, Patterson F. Sex heterogeneity in pharmacogenetic smoking cessation clinical trials. Drug Alcohol Depend. 2009;104 Suppl 1:S94–9. doi:10.1016/j.drugalcdep.2008.11.012.
14. Piper ME, Cook JW, Schlam TR, Jorenby DE, Smith SS, Bolt DM, et al. Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials. Nicotine Tob Res. 2010;12(6):647–57. doi:10.1093/ntr/ntq067.
15. Cepeda-Benito A, Reynoso JT, Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. J Consult Clin Psychol. 2004;72(4):712–22.
16. Printz C. Lung cancer new leading cause of death for women in developed countries: data reflects increased rates of smoking. Cancer. 2015;121(12):1911–2. doi:10.1002/cncr.28995.
17. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 2011;378(9799):1297–305. doi:10.1016/S0140-6736(11)60781-2.
18. Yen SSC, Jaffee RB, Barbieri RL. Reproductive endocrinology: physiology, pathophysiology and clinical management. Philadelphia: W.B. Saunders Company; 1999.
19. Allen AM, McRae-Clark AL, Carlson S, Saladin ME, Gray KM, Wetherington CL et al. Determining menstrual phase in human biobehavioral research: a review with recommendations. Exp Clin Psychopharmacol. in press.
20. Czoty PW, Riddick NV, Gage HD, Sandridge M, Nader SH, Garg S, et al. Effect of menstrual cycle phase on dopamine D2 receptor availability in female cynomolgus monkeys. Neuropsychopharmacology. 2009;34(3):548–54. doi:10.1038/npp.2008.3.
21. Lynch WJ. Acquisition and maintenance of cocaine self-administration in adolescent rats: effects of sex and gonadal hormones. Psychopharmacology (Berl). 2008;197(2):237–46. doi:10.1007/s00213-007-1028-0.
22. Lynch WJ, Roth ME, Carroll ME. Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology (Berl). 2002;164(2):121–37. doi:10.1007/s00213-002-1183-2.
23. Lynch WJ, Sofuoglu M. Role of progesterone in nicotine addiction: evidence from initiation to relapse. Exp Clin Psychopharmacol. 2010;18(6):451–61. doi:10.1037/a0021265.
24. Thompson TL, Moss RL. Estrogen regulation of dopamine release in the nucleus accumbens: genomic- and nongenomic-mediated effects. J Neurochem. 1994;62(5):1750–6.
25. Dluzen DE, Anderson LI. Estrogen differentially modulates nicotine-evoked dopamine release from the striatum of male and female rats. Neurosci Lett. 1997;230(2):140–2.
26. Allen SS, Allen AM, Lunos S, Hatsukami DK. Patterns of self-selected smoking cessation attempts and relapse by menstrual phase. Addict Behav. 2009;34(11):928–31. doi:10.1016/j.addbeh.2009.05.013.
27. Dempsey D, Jacob 3rd P, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther. 2002;301(2):594–8.
28. Weinberger AH, Smith PH, Allen SS, Cosgrove KP, Saladin ME, Gray KM, et al. Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation. Nicotine Tob Res. 2015;17(4):407–21. doi:10.1093/ntr/ntu249.
29. Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob 3rd P. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther. 2006;79(5):480–8.
30. Sofuoglu M, Babb DA, Hatsukami DK. Progesterone treatment during the early follicular phase of the menstrual cycle: effects on smoking behavior in women. Pharmacol Biochem Behav. 2001;69(1-2):299–304.
31. Sofuoglu M, Mitchell E, Mooney M. Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. Hum Psychopharmacol. 2009;24(7):559–64. doi:10.1002/hup.1055.
32. Shiffman S, Paty JA, Gnys M, Kassel JA, Hickcox M. First lapses to smoking: within-subjects analysis of real-time reports. J Consult Clin Psychol. 1996;64(2):366–79.
33. Franklin TR, Jagannathan K, Wetherill RR, Johnson B, Kelly S, Langguth J, et al. Influence of menstrual cycle phase on neural and craving responses to appetitive smoking cues in naturally cycling females. Nicotine Tob Res. 2015;17(4):390–7. doi:10.1093/ntr/ntu183. This study showed that women in the follicular phase of their menstrual cycle exhibited greater neural activiation to smoking cues relative to nonsmoking cues) in brain regions commonly associated with reward processes. Further, follicular phase women reported smoking cue-elicited craving, which correlated with smoking cue-elicited neural activation in the insula; whereas, luteal women did not.
34. Mendrek A, Dinh-Williams L, Bourque J, Potvin S. Sex differences and menstrual cycle phase-dependent modulation of craving for cigarette: an FMRI pilot study. Psychiatry J. 2014;2014:723632. doi:10.1155/2014/723632.
35. Studer B, Cen D, Walsh V. The angular gyrus and visuospatial attention in decision-making under risk. NeuroImage. 2014;103:75–80. doi:10.1016/j.neuroimage.2014.09.003.
36. Torres OV, O’Dell LE. Stress is a principal factor that promotes tobacco use in females. Prog Neuropsychopharmacol Biol Psychiatry. 2015. doi:10.1016/j.pnpbp.2015.04.005.
37. Buchmann AF, Laucht M, Schmid B, Wiedemann K, Mann K, Zimmermann US. Cigarette craving increases after a psychosocial stress test and is related to cortisol stress response but not to dependence scores in daily smokers. J Psychopharmacol. 2010;24(2):247–55. doi:10.1177/0269881108095716.
38. McKee SA, Sinha R, Weinberger AH, Sofuoglu M, Harrison EL, Lavery M, et al. Stress decreases the ability to resist smoking and potentiates smoking intensity and reward. J Psychopharmacol. 2011;25(4):490–502. doi:10.1177/0269881110376694.
39. Schmaus BJ, Laubmeier KK, Boquiren VM, Herzer M, Zakowski SG. Gender and stress: differential psychophysiological reactivity to stress reexposure in the laboratory. Int J Psychophysiol. 2008;69(2):101–6. doi:10.1016/j.ijpsycho.2008.03.006.
40. Saladin ME, Gray KM, Carpenter MJ, LaRowe SD, DeSantis SM, Upadhyaya HP. Gender differences in craving and cue reactivity to smoking and negative affect/stress cues. Am J Addict. 2012;21(3):210–20. doi:10.1111/j.1521-0391.2012.00232.x.
41. Saladin ME, Wray JM, Carpenter MJ, McClure EA, LaRowe SD, Upadhyaya HP, et al. Menstrual cycle phase effects in the gender dimorphic stress cue reactivity of smokers. Nicotine Tob Res. 2015;17(5):607–11. doi:10.1093/ntr/ntu203. Very important study with innovative and strong research methodology demonstrating the direct effects of progesterone on medication-assisted smoking cessation.
42. Saladin ME, McClure EA, Baker NL, Carpenter MJ, Ramakrishnan V, Hartwell KJ, et al. Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy. Nicotine Tob Res. 2015;17(4):398–406. doi:10.1093/ntr/ntu262.
43. Sofuoglu M, Mouratidis M, Mooney M. Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology. 2011;36(1):123–32. doi:10.1016/j.psyneuen.2010.07.005.
44. Allen SS, Bade T, Center B, Finstad D, Hatsukami D. Menstrual phase effects on smoking relapse. Addiction. 2008;103(5):809–21. doi:10.1111/j.1360-0443.2008.02146.x.
45. Allen SS, Allen AM, Tosun N, Lunos S, al’absi M, Hatsukami D. Smoking- and menstrual-related symptomatology during short-term smoking abstinence by menstrual phase and depressive symptoms. Addict Behav. 2014;39(5):901–6. doi:10.1016/j.addbeh.2014.01.029. Important study using controlled cross-over design to examine the effects of menstrual phase, depressive symptoms, and the combined effect of menstrual phase and depressive symptoms on smoking- and menstrual-related symptomatology during acute smoking abstinence. Several secondary analyses have been published from this main study.
46. Allen AM, al’Absi M, Lando H, Allen SS. Allopregnanolone association with psychophysiological and cognitive functions during acute smoking abstinence in premenopausal women. Exp Clin Psychopharmacol. 2015;23(1):22–8. doi:10.1037/a0038747.
47. Allen AM, al’Absi M, Lando H, Hatsukami D, Allen SS. Menstrual phase, depressive symptoms, and allopregnanolone during short-term smoking cessation. Exp Clin Psychopharmacol. 2013;21(6):427–33. doi:10.1037/a0034075.
48. Allen AM, Lunos S, Heishman SJ, al’Absi M, Hatsukami D, Allen SS. Subjective response to nicotine by menstrual phase. Addict Behav. 2015;43:50–3. doi:10.1016/j.addbeh.2014.12.008.
49. Allen SS, Allen AM, Kotlyar M, Lunos S, Al’absi M, Hatsukami D. Menstrual phase and depressive symptoms differences in physiological response to nicotine following acute smoking abstinence. Nicotine Tob Res. 2013;15(6):1091–8. doi:10.1093/ntr/nts236.
50. Hinderaker K, Allen AM, Tosun N, al’Absi M, Hatsukami D, Allen SS. The effect of combination oral contraceptives on smoking-related symptomatology during short-term smoking abstinence. Addict Behav. 2015;41:148–51. doi:10.1016/j.addbeh.2014.10.018.
51. Huttlin EA, Allen AM, Tosun NL, Allen SS, al’Absi M. Associations between adrenocortical activity and nicotine response in female smokers by menstrual phase. Addict Behav. 2015;50:135–9. doi:10.1016/j.addbeh.2015.06.026.
52. DeVito EE, Herman AI, Waters AJ, Valentine GW, Sofuoglu M. Subjective, physiological, and cognitive responses to intravenous nicotine: effects of sex and menstrual cycle phase. Neuropsychopharmacology. 2014;39(6):1431–40. doi:10.1038/npp.2013.339.
53. Schiller CE, Saladin ME, Gray KM, Hartwell KJ, Carpenter MJ. Association between ovarian hormones and smoking behavior in women. Exp Clin Psychopharmacol. 2012;20(4):251–7. doi:10.1037/a0027759.
54. Goletiani NV, Siegel AJ, Lukas SE, Hudson JI. The effects of smoked nicotine on measures of subjective States and hypothalamic-pituitary-adrenal axis hormones in women during the follicular and luteal phases of the menstrual cycle. J Addict Med. 2015;9(3):195–203. doi:10.1097/ADM.0000000000000117.